Goldman Sachs’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $852M | Sell |
14,054,518
-4,288,459
| -23% | -$250M | 0.1% | 196 |
|
|
2025
Q4 | $989M | Buy |
18,342,977
+757,995
| +4% | +$36.5M | 0.12% | 145 |
|
|
2025
Q3 | $793M | Buy |
17,584,982
+5,273,954
| +43% | +$246M | 0.1% | 183 |
|
|
2025
Q2 | $570M | Sell |
12,311,028
-934,191
| -7% | -$45.9M | 0.08% | 244 |
|
|
2025
Q1 | $808M | Buy |
13,245,219
+941,849
| +8% | +$54.9M | 0.13% | 141 |
|
|
2024
Q4 | $696M | Sell |
12,303,370
-406,932
| -3% | -$22.7M | 0.11% | 160 |
|
|
2024
Q3 | $658M | Sell |
12,710,302
-3,030,425
| -19% | -$142M | 0.11% | 179 |
|
|
2024
Q2 | $654M | Sell |
15,740,727
-230,832
| -1% | -$10.3M | 0.11% | 174 |
|
|
2024
Q1 | $866M | Sell |
15,971,559
-387,977
| -2% | -$19.8M | 0.15% | 125 |
|
|
2023
Q4 | $839M | Sell |
16,359,536
-984,542
| -6% | -$51.7M | 0.15% | 123 |
|
|
2023
Q3 | $1.01B | Buy |
17,344,078
+840,138
| +5% | +$51.5M | 0.21% | 82 |
|
|
2023
Q2 | $1.06B | Sell |
16,503,940
-669,878
| -4% | -$44.9M | 0.23% | 69 |
|
|
2023
Q1 | $1.19B | Buy |
17,173,818
+1,470,325
| +9% | +$104M | 0.27% | 57 |
|
|
2022
Q4 | $1.13B | Buy |
15,703,493
+162,073
| +1% | +$12.2M | 0.28% | 51 |
|
|
2022
Q3 | $1.1B | Buy |
15,541,420
+1,184,317
| +8% | +$85.9M | 0.28% | 50 |
|
|
2022
Q2 | $1.11B | Sell |
14,357,103
-1,751,823
| -11% | -$133M | 0.28% | 52 |
|
|
2022
Q1 | $1.18B | Buy |
16,108,926
+4,114,062
| +34% | +$276M | 0.25% | 55 |
|
|
2021
Q4 | $748M | Sell |
11,994,864
-2,270,599
| -16% | -$133M | 0.15% | 113 |
|
|
2021
Q3 | $844M | Buy |
14,265,463
+1,574,543
| +12% | +$104M | 0.18% | 89 |
|
|
2021
Q2 | $848M | Sell |
12,690,920
-987,076
| -7% | -$64.4M | 0.19% | 81 |
|
|
2021
Q1 | $863M | Buy |
13,677,996
+4,085,439
| +43% | +$254M | 0.22% | 65 |
|
|
2020
Q4 | $595M | Buy |
9,592,557
+1,000,142
| +12% | +$61.5M | 0.15% | 114 |
|
|
2020
Q3 | $518M | Sell |
8,592,415
-7,797,577
| -48% | -$469M | 0.15% | 122 |
|
|
2020
Q2 | $964M | Buy |
16,389,992
+923,504
| +6% | +$55.2M | 0.29% | 50 |
|
|
2020
Q1 | $862M | Sell |
15,466,488
-1,873,665
| -11% | -$115M | 0.3% | 57 |
|
|
2019
Q4 | $1.11B | Buy |
17,340,153
+7,024,051
| +68% | +$402M | 0.28% | 58 |
|
|
2019
Q3 | $523M | Sell |
10,316,102
-308,647
| -3% | -$14.5M | 0.15% | 117 |
|
|
2019
Q2 | $482M | Sell |
10,624,749
-531,821
| -5% | -$24.8M | 0.14% | 135 |
|
|
2019
Q1 | $532M | Sell |
11,156,570
-918,233
| -8% | -$45.7M | 0.16% | 107 |
|
|
2018
Q4 | $628M | Sell |
12,074,803
-1,203,327
| -9% | -$64.7M | 0.2% | 83 |
|
|
2018
Q3 | $824M | Buy |
13,278,130
+1,520,575
| +13% | +$90.2M | 0.21% | 76 |
|
|
2018
Q2 | $651M | Sell |
11,757,555
-2,435,505
| -17% | -$132M | 0.18% | 92 |
|
|
2018
Q1 | $898M | Buy |
14,193,060
+3,023,049
| +27% | +$194M | 0.23% | 71 |
|
|
2017
Q4 | $684M | Sell |
11,170,011
-1,014,106
| -8% | -$63.4M | 0.16% | 106 |
|
|
2017
Q3 | $777M | Buy |
12,184,117
+1,857,623
| +18% | +$108M | 0.19% | 75 |
|
|
2017
Q2 | $575M | Sell |
10,326,494
-434,424
| -4% | -$23.6M | 0.15% | 111 |
|
|
2017
Q1 | $585M | Buy |
10,760,918
+4,038,096
| +60% | +$221M | 0.16% | 105 |
|
|
2016
Q4 | $393M | Sell |
6,722,822
-108,451
| -2% | -$5.93M | 0.11% | 163 |
|
|
2016
Q3 | $368M | Buy |
6,831,273
+897,835
| +15% | +$57.7M | 0.11% | 163 |
|
|
2016
Q2 | $436M | Buy |
5,933,438
+683,786
| +13% | +$48.3M | 0.14% | 113 |
|
|
2016
Q1 | $335M | Buy |
5,249,652
+262,049
| +5% | +$16.5M | 0.11% | 173 |
|
|
2015
Q4 | $343M | Sell |
4,987,603
-893,871
| -15% | -$59.1M | 0.11% | 182 |
|
|
2015
Q3 | $348M | Sell |
5,881,474
-378,382
| -6% | -$24M | 0.12% | 156 |
|
|
2015
Q2 | $417M | Sell |
6,259,856
-356,317
| -5% | -$23.5M | 0.13% | 146 |
|
|
2015
Q1 | $427M | Sell |
6,616,173
-1,430,320
| -18% | -$89.5M | 0.14% | 142 |
|
|
2014
Q4 | $475M | Buy |
8,046,493
+505,143
| +7% | +$28.5M | 0.15% | 119 |
|
|
2014
Q3 | $386M | Buy |
7,541,350
+720,694
| +11% | +$36M | 0.12% | 143 |
|
|
2014
Q2 | $331M | Buy |
6,820,656
+123,383
| +2% | +$6.08M | 0.1% | 191 |
|
|
2014
Q1 | $348M | Buy |
6,697,273
+709,608
| +12% | +$37.8M | 0.11% | 172 |
|
|
2013
Q4 | $318M | Sell |
5,987,665
-48,610
| -0.8% | -$2.48M | 0.1% | 198 |
|
|
2013
Q3 | $279M | Sell |
6,036,275
-1,731,194
| -22% | -$76M | 0.1% | 193 |
|
|
2013
Q2 | $347M | Buy |
+7,767,469
| New | +$337M | 0.13% | 139 |
|
Other funds holding BMY
VCM
VPM
Goldman Sachs's BMY Position: Q1 2026 in Review
Goldman Sachs reduced its Bristol-Myers Squibb (BMY) stake by 23% in Q1 2026, selling an estimated $250M and leaving 14,054,518 shares worth $852M. The position accounts for 0.1% of the portfolio, ranked #196.
Goldman Sachs first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.19B in Q1 2023. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Goldman Sachs held 14,054,518 shares of Bristol-Myers Squibb worth $852M as of Q1 2026.
- Goldman Sachs sold 4,288,459 Bristol-Myers Squibb shares in Q1 2026, an estimated $250M.
- Bristol-Myers Squibb made up 0.1% of Goldman Sachs's portfolio in Q1 2026, its #196 holding.
- Goldman Sachs first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Bristol-Myers Squibb position peaked at $1.19B in Q1 2023.
- 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.